A combination regimen by lopinave/litonawe, emtricitabine and tenofovir alafenamide fumarate for treatment of novel coronavirus pneumonia (TARCoV)
Chinese Journal of Emergency Medicine
; 29(3):346-349, 2020.
Article
in Chinese
| GIM | ID: covidwho-1125321
ABSTRACT
Objective:
To explore the efficacy of a combination regimen by Lopinave/Litonawe (LPV/r), emtricitabine and tenofovir alafenamide fumarate (FTC/TAF) for the treatment of novel coronavirus pneumonia.
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Language:
Chinese
Journal:
Chinese Journal of Emergency Medicine
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS